Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would not wait six months and I would not “wait for more data” before acting. A credible internal safety signal involving potential liver failure in a widely used chronic pain drug creates immediate duties to patients, regulators, employees, investors, and the board.Read the full answer



